NORRETT KEVIN (Chief Business Officer) received a stock award from SOLENO THERAPEUTICS INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 11/19/2025ACC: 0001819690-25-000008
Officer· Chief Business Officer
Since Nov 2025
+78.57K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
78.57K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+14.29K
Price / share
—
Trade value
—
% of position
New position
11/17/2025
0.00→14.29K
Total
Net shares
+14.29K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/17/2025 | A · Award | +14.29K | — | — | New position | 0.00 | 14.29K |
| Total | +14.29K | $0.00 | ||||||
Derivative Transactions1
Employee stock option (right to buy)
Direct
Converts to
Common Stock
64.29K shares
Shares
+64.29K
Strike price
47.25
Held after
64.29K
Exercisable
—
11/17/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee stock option (right to buy) Direct | Common Stock64.29K shares | 11/17/2025 | M · Option Exercise | +64.29K | 47.25 | — | 64.29K |